Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Summit, NJ
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Summit, NJ
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Toms River, NJ
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Toms River, NJ
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Orangeburg, NY
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Orangeburg, NY
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Rochester, NY
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
White Plains, NY
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
White Plains, NY
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Centerville, OH
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Centerville, OH
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Cincinnati, OH
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Cleveland, OH
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Columbus, OH
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Lakewood, OH
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Lakewood, OH
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Allentown, PA
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Reading, PA
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Reading, PA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Charleston, SC
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Houston, TX
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
San Antonio, TX
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Bennington, VT
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Bennington, VT
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Spokane, WA
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Rosuvastatin (Crestor) in Friedreich Ataxia
Open-label Biomarker Study of Rosuvastatin (Crestor) for the Treatment of Patients With Friedreich Ataxia
Status: Enrolling
Updated:  1/8/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Rosuvastatin (Crestor) in Friedreich Ataxia
Open-label Biomarker Study of Rosuvastatin (Crestor) for the Treatment of Patients With Friedreich Ataxia
Status: Enrolling
Updated: 1/8/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Allergy Testing of Patients Labeled as Penicillin Allergic
Allergy Testing of Primary Care Patients Labeled as Penicillin Allergic
Status: Enrolling
Updated:  1/8/2018
Albany Medical College Allergy, Asthma and Immunology Center
mi
from
Albany, NY
Allergy Testing of Patients Labeled as Penicillin Allergic
Allergy Testing of Primary Care Patients Labeled as Penicillin Allergic
Status: Enrolling
Updated: 1/8/2018
Albany Medical College Allergy, Asthma and Immunology Center
mi
from
Albany, NY
Click here to add this to my saved trials
Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel
Cold Therapy to Prevent Paclitaxel-Induced Peripheral Neuropathy and Cutaneous Toxicity
Status: Enrolling
Updated:  1/9/2018
Northwestern University
mi
from
Chicago, IL
Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel
Cold Therapy to Prevent Paclitaxel-Induced Peripheral Neuropathy and Cutaneous Toxicity
Status: Enrolling
Updated: 1/9/2018
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Banner Desert Medical Center
mi
from
Mesa, AZ
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Banner Desert Medical Center
mi
from
Mesa, AZ
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Eden Medical Center
mi
from
Castro Valley, CA
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Eden Medical Center
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
St. Jude Medical Center
mi
from
Fullerton, CA
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
St. Jude Medical Center
mi
from
Fullerton, CA
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
UCLA Medical Center
mi
from
Los Angeles, CA
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Good Samaritan Hospital Regional Medical Center
mi
from
San Jose, CA
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Good Samaritan Hospital Regional Medical Center
mi
from
San Jose, CA
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Los Robles Hospital and Medical Center
mi
from
Thousand Oaks, CA
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Los Robles Hospital and Medical Center
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Yale University-Yale New Haven Hospital
mi
from
New Haven, CT
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Yale University-Yale New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Christiana Hospital
mi
from
Newark, DE
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Christiana Hospital
mi
from
Newark, DE
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Memorial Regional Hospital
mi
from
Hollywood, FL
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Memorial Regional Hospital
mi
from
Hollywood, FL
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
University of Miami (Jackson Memorial)
mi
from
Miami, FL
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
University of Miami (Jackson Memorial)
mi
from
Miami, FL
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Florida Hospital
mi
from
Orlando, FL
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Emory University and Grady Memorial Hospital
mi
from
Atlanta, GA
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Emory University and Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Wellstar Kennestone Hospital
mi
from
Marietta, GA
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Wellstar Kennestone Hospital
mi
from
Marietta, GA
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Advocate Christ Lutheran Hospital
mi
from
Park Ridge, IL
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Advocate Christ Lutheran Hospital
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Peoria Radiology Research & Education Foundation
mi
from
Peoria, IL
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Peoria Radiology Research & Education Foundation
mi
from
Peoria, IL
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Baptist Health Lexington
mi
from
Lexington, KY
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Baptist Health Lexington
mi
from
Lexington, KY
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
University of Kentucky
mi
from
Lexington, KY
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
University of Maryland Medical Center
mi
from
Baltimore, MD
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
St. Joseph Mercy
mi
from
Pontiac, MI
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
St. Joseph Mercy
mi
from
Pontiac, MI
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Capital Health System
mi
from
Trenton, NJ
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Capital Health System
mi
from
Trenton, NJ
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Buffalo General Medical Center
mi
from
Buffalo, NY
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Buffalo General Medical Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Mission Hospital, Inc
mi
from
Asheville, NC
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Mission Hospital, Inc
mi
from
Asheville, NC
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Ohio State University Medical Center
mi
from
Columbus, OH
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Riverside Methodist Hospital/ Ohio Health Research Institute
mi
from
Columbus, OH
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Riverside Methodist Hospital/ Ohio Health Research Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Oregon Stroke Center, Oregon Health & Science University (OHSU)
mi
from
Portland, OR
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Oregon Stroke Center, Oregon Health & Science University (OHSU)
mi
from
Portland, OR
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Abington Memorial Hospital
mi
from
Abington, PA
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
UPMC Presbyterian
mi
from
Pittsburgh, PA
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
UPMC Presbyterian
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
Erlanger Hospital
mi
from
Chattanooga, TN
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Erlanger Hospital
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
University of Tennessee Medical Center at Knoxville
mi
from
Knoxville, TN
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
University of Tennessee Medical Center at Knoxville
mi
from
Knoxville, TN
Click here to add this to my saved trials